Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 8 Neoplasms 3 Hemangioma, Capillary 2 Anxiety Disorders 2 Weight Loss 1 Vomiting 1 Urinary Incontinence, Stress 1 Urinary Incontinence 1 Urinary Bladder Neoplasms 1 Shoulder Pain 1 Respiratory Aspiration 1 Psychomotor Agitation 1 Prostatic Neoplasms 1 Premature Birth 1 Polycystic Ovary Syndrome 1 Pediatric Obesity 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Ovarian Cysts 1 Obesity 1 Neuromuscular Diseases 1 Neuroblastoma 1 Nasopharyngeal Carcinoma 1 Myofibroma 1 Myelodysplastic Syndromes 1 Myasthenia Gravis 1 Multiple Myeloma 1 Menstruation Disturbances 1 Lymphoma, Follicular 1 Lung Neoplasms 1

Interventions

Gemcitabine 87 Cisplatin 66 Cystectomy 38 pembrolizumab 34 Docetaxel 25 Nivolumab 24 durvalumab 21 Paclitaxel 19 Magnetic Resonance Spectroscopy 18 Radiotherapy 17 Mitomycin 17 Carboplatin 16 atezolizumab 15 Doxorubicin 14 Cystoscopy 14 BCG Vaccine 13 Surveys and Questionnaires 12 Standard of Care 12 avelumab 11 Sunitinib 10 tremelimumab 9 Transurethral Resection of Bladder 9 Ipilimumab 9 Filgrastim 9 Blood Specimen Collection 9 Specimen Handling 8 Neoadjuvant Therapy 8 Methotrexate 8 Methods 8 Early Intervention, Educational 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Urinary Bladder Neoplasms × Population Groups × Clear all

NCT02676180 2023-12-08

DETECT I

University College, London

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡